ATLAS VENTURE ASSOCIATES X, L.P.

CIK 1742766 · last filed 2024-03-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$920.97M
Companies
6
Total Filings
12
Lifetime Open-Market Net
-$87.26M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

KYMR price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
400 TECHNOLOGY SQ.
10TH FLOOR
CAMBRIDGE, MA 02139
Phone
(857) 201-2700
State of Incorporation
DE
Related Filers
Atlas Venture Associates X, LLC — 38 joint filings, latest 2026-02-09
Atlas Venture Fund X, L.P. — 29 joint filings, latest 2026-02-09
Atlas Venture Associates Opportunity I, LLC — 24 joint filings, latest 2026-02-09
Atlas Venture Opportunity Fund I, L.P. — 23 joint filings, latest 2026-02-09
Atlas Venture Associates Opportunity I, L.P. — 21 joint filings, latest 2026-02-09
Atlas Venture Fund XI, L.P. — 3 joint filings, latest 2021-05-26
Atlas Venture Associates Opportunity II, LLC — 2 joint filings, latest 2024-03-27
Atlas Venture Associates XI, L.P. — 2 joint filings, latest 2021-04-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KYMR 10%+ Owner 5,504,905 $119.72 $659.05M -$49.24M 5 2024-03-13
IRON 10%+ Owner 2,285,846 $76.69 $175.30M -$30.53M 2 2023-12-14
Generation Bio Co. (GBIO) Delisted 10%+ Owner 911,194 $5.34 $4.87M -$7.23M 2 2021-04-14
Tectonic Therapeutic, Inc. (AVRO) Delisted 10%+ Owner 309,171 $16.80 $5.19M $0 1 2020-02-18
Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted 10%+ Owner 258,210 $11.19 $2.89M -$254.4K 1 2019-03-22
REPL 10%+ Owner 4,453,386 $19.45 $86.62M $0 1 2018-07-26

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
KYMR Direct 4,676,075 84.9% 2024-03-13
Atlas Venture Opportunity Fund I, L.P.
See footnote
828,830 15.1% 2024-03-13
Total 5,504,905
IRON Direct 1,479,686 64.7% 2023-12-14
Atlas Venture Opportunity Fund I, L.P.
See footnote
806,160 35.3% 2023-12-14
Total 2,285,846
GBIO Direct 0 0.0% 2021-04-14
Atlas Venture Fund X, L.P.
See footnote
911,194 100.0% 2021-04-14
Total 911,194
MGTA Direct 257,320 99.7% 2019-03-22
AVA X LP
See Footnote
890 0.3% 2019-03-22
Total 258,210

Recent Filings · Page 2 of 2

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2019-03-22 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Mixed −726,500 -$254.4K EDGAR
2018-07-26 REPL Conv (C) +4,453,386 $0 EDGAR
Showing 11–12 of 12
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).